Printer Friendly

GreenLight Biosciences names new chief financial officer.

M2 PHARMA-June 12, 2019-GreenLight Biosciences names new chief financial officer

(C)2019 M2 COMMUNICATIONS

It was reported yesterday that GreenLight Biosciences Inc, a bio-performance company developing RNA-based solutions for agriculture and pharmaceutical applications, has named Susan Keefe as its new chief financial officer.

The new chief financial officer is to lead the company's financial strategy and facilitate its growth plan, and will be responsible for managing all aspects of GreenLight's financial operations.

Prior to joining GreenLight, Keefe worked for 25 years in financial positions across the biotech, consumer packaged goods and health care industries. Most recently, she served as financial consultant to a range of life science companies with Danforth Advisors.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2019 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Jun 12, 2019
Words:122
Previous Article:AptarGroup acquires Nanopharm and Gateway Analytical.
Next Article:Amcor completes acquisition of Bemis Company.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters